Turning Point: The Quest for a Cure
BrightFocus Foundation is a presentation partner for Turning Point, an award-winning documentary capturing the drama and dedication of scientists and clinical trial volunteers who are working to make Alzheimer’s a distant memory.
Working with Gates Ventures and public and private sector leaders, BrightFocus has screened the film nationally and internationally for community audiences, health care and scientific groups, and policymakers.
“Turning Point is an excellent documentary that gives us an inside look at the doctors, scientists, and patients who are working to uncover the mysteries of Alzheimer’s disease through clinical trials. Everybody should see this film.”- Bill Gates
The Quest for an Alzheimer’s Cure
Watch Now
Rent or purchase the full documentary, Turning Point: The Quest for a Cure, on one of these trusted streaming platforms.
Funded by:
The film was funded through a grant by Eli Lilly and Company to Volunteers of America. PCH Films retained full editorial control of all content and messaging in the film.
Related Resources
Related Resources & Information
When A Loved One With Alzheimer’s Lives Alone
If you’ve ever tried to convince someone with Alzheimer’s or dementia to move from their home, you know how difficult it is. Home provides a sense of familiarity and remaining in one’s home also reinforces a feeling of independence. A common question families ask is, “Is it safe for my loved one to stay in their home, at least for a while?”
Alzheimer’s Blood Biomarker & Genetic Tests: Legal & Ethical Considerations
Jalayne J. Arias discusses the legal and ethical implications of Alzheimer’s biomarker and genetic testing, including what individuals and families should know before getting tested.
What’s Next in Alzheimer’s Research: Understanding the Brain as an Integrated System
Thanks to the generous support of our donors, BrightFocus Foundation’s Alzheimer’s Disease Research program is investing in cutting-edge ideas to better understand, treat, and cure the disease.
From Schizophrenia to Alzheimer’s: Understanding the KarXT Clinical Trials
Could a breakthrough drug originally approved for schizophrenia help address some of the most challenging symptoms of Alzheimer’s disease? Dr. Paul Newhouse explains the emerging science behind KarXT (now FDA-approved for schizophrenia as Cobenfy).
More Than a Card Game: Supporting Alzheimer’s Disease Research
For the past four years, Scott Miller’s family and friends have honored the memories of his father and father-in-law through donations to Alzheimer’s Disease Research, helping advance promising discoveries and bring hope to families affected by this devastating disease.
What’s New in Alzheimer’s Blood Testing
In this timely discussion, Dr. Suzanne Schindler will explain how blood-based biomarkers are transforming Alzheimer’s diagnosis, research, and care.
Trontinemab: A New Brain-Penetrant Alzheimer’s Therapy
Dr. Gil Rabinovici explores trontinemab, an investigational next-generation anti-amyloid therapy being studied for early Alzheimer’s disease.
Reducing Dementia Risk: What New Research Reveals
Dr. Zaldy Tan discusses what the newest research reveals about protecting brain health and promoting healthy aging.
Lewy Body, Alzheimer’s & Mixed Dementias Explained
Leading neurologist Dr. James E. Galvin explains how to identify early warning signs, distinguish Lewy body dementia from Alzheimer’s disease, and explore current and emerging treatment options.
When A Loved One With Alzheimer’s Lives Alone
If you’ve ever tried to convince someone with Alzheimer’s or dementia to move from their home, you know how difficult it is. Home provides a sense of familiarity and remaining in one’s home also reinforces a feeling of independence. A common question families ask is, “Is it safe for my loved one to stay in their home, at least for a while?”
Alzheimer’s Blood Biomarker & Genetic Tests: Legal & Ethical Considerations
Jalayne J. Arias discusses the legal and ethical implications of Alzheimer’s biomarker and genetic testing, including what individuals and families should know before getting tested.
What’s Next in Alzheimer’s Research: Understanding the Brain as an Integrated System
Thanks to the generous support of our donors, BrightFocus Foundation’s Alzheimer’s Disease Research program is investing in cutting-edge ideas to better understand, treat, and cure the disease.
From Schizophrenia to Alzheimer’s: Understanding the KarXT Clinical Trials
Could a breakthrough drug originally approved for schizophrenia help address some of the most challenging symptoms of Alzheimer’s disease? Dr. Paul Newhouse explains the emerging science behind KarXT (now FDA-approved for schizophrenia as Cobenfy).
More Than a Card Game: Supporting Alzheimer’s Disease Research
For the past four years, Scott Miller’s family and friends have honored the memories of his father and father-in-law through donations to Alzheimer’s Disease Research, helping advance promising discoveries and bring hope to families affected by this devastating disease.
What’s New in Alzheimer’s Blood Testing
In this timely discussion, Dr. Suzanne Schindler will explain how blood-based biomarkers are transforming Alzheimer’s diagnosis, research, and care.
Trontinemab: A New Brain-Penetrant Alzheimer’s Therapy
Dr. Gil Rabinovici explores trontinemab, an investigational next-generation anti-amyloid therapy being studied for early Alzheimer’s disease.
Reducing Dementia Risk: What New Research Reveals
Dr. Zaldy Tan discusses what the newest research reveals about protecting brain health and promoting healthy aging.
Lewy Body, Alzheimer’s & Mixed Dementias Explained
Leading neurologist Dr. James E. Galvin explains how to identify early warning signs, distinguish Lewy body dementia from Alzheimer’s disease, and explore current and emerging treatment options.